Sunitinib safe, effective in patients with mRCC, renal insufficiency

Sunitinib demonstrated encouraging activity and manageable toxicities in patients with metastatic renal cell carcinoma and renal insufficiency, according to study results.02/14/2014
Source: Kidney Cancer Association - Category: Cancer & Oncology Source Type: news